Updates from ASH22 on MDS and AML | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Updates from ASH22 on MDS and AML

ASH22 Updates on M-D-S and A-M-L
Myelodysplastic Syndromes (MDS)
Acute Myeloid Leukemia (AML)
Presentation Date: 
Thu, 04/06/2023 - 2:00pm (EDT)

In this webinar, Dr. Lourdes Mendez discusses research most relevant to patients reported over the past year on the biology and treatment on MDS and secondary AML. These studies were presented at the American Society of Hematology (ASH) 2022 meeting.  Research findings are explained along with the potential impact of this research on understanding and treating MDS and AML. This is an advanced scientific presentation. The question and answer session is included in this recording.